A1c Below ADA Target in Six Months: New Nourish Data Shows the Impact of Dietitian-Led Care on Blood Sugar for Adults with Diabetes

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Real-world study presented at ObesityWeek, the world’s largest conference on obesity, found improvements in blood sugar for adults with diabetes, including those with no GLP-1 exposure.

Nourish, the country's largest dietitian-led metabolic health clinic, presented results from a new real-world study this week at ObesityWeek, the premier conference focused on obesity research, treatment, prevention, and public policy. Among more than 2,000 adults with type 2 diabetes who stayed engaged in Nourish care for six months, working with a registered dietitian was associated with a clinically meaningful improvement in blood sugar.

Key findings

  • 1.37 point A1c reduction: Steady improvement in A1c yielded a 1.15 point reduction after three months, and an average total reduction of 1.37 points after six months
  • Improvement in adults not on GLP-1s: Results from this study were observed across medication profiles, including among adults with no GLP-1 exposure

To put that 1.37-point reduction in context, existing literature suggests that each percentage-point of improved A1c is associated with a 21% lower relative risk of diabetes-related complications, and a 37% lower relative risk of microvascular disease. These numbers are encouraging, given that type 2 diabetes affects around 1 in 10 U.S. adults and is a leading driver of preventable morbidity in this country.

While medical nutrition therapy is a recommended part of the management of type 2 diabetes, real-world evidence on outcomes from virtual care models remains limited. These results suggest that dietitian-led care contributes to improvements in blood sugar beyond concurrent medication use.

The retrospective analysis presented by the Nourish clinical research team included adults with type 2 diabetes who had at least one follow-up A1c measurement, and remained engaged in care over the course of six months (n=2,444). At Nourish, a registered dietitian serves as the entry point to care for all patients, with AI-powered support between visits.

“While GLP-1s have captured much of the attention in diabetes care, effective treatment goes well beyond any single medication,” said Nourish CMO Dr. Ajay Haryani. “Regardless of a patient’s medication regimen, consistent, longitudinal support from a Registered Dietitian is essential to improving glycemic control and sustaining those improvements over time. Our data showed that more than half of patients who started above the ADA’s glycemic target achieved that target within six months. It’s a powerful case for making nutrition care a foundational part of diabetes treatment for every patient.”

For more detail, see the poster here.

About Nourish

Nourish is the country's largest dietitian-led metabolic health clinic, building the first AI-native virtual care model to tackle America's healthcare crisis and reverse chronic disease. The company pairs 10,000+ Registered Dietitians with AI agents to deliver insurance-covered, personalized care that produces best-in-class outcomes. For patients who need access, Nourish integrates GLP-1 medication management, lab testing, and medical care into one care model designed for sustained behavior change. Through partnerships with the nation's largest health plans, health systems, and employers, Nourish is available to over 200 million Americans across all 50 states, typically at no cost. Learn more at https://www.nourish.com/.

About ObesityWeek

The Obesity Society’s annual meeting brings together cutting-edge basic and clinical research, state-of-the-art treatment and prevention strategies, the latest advances in advocacy and public policy, real-world insights, and meaningful collaboration to move the field forward. Because obesity is a complex chronic disease, effective treatment requires a multidisciplinary approach. ObesityWeek brings together the full spectrum of obesity science—from basic research to translational studies and clinical application, to policy and population health.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  256.06
-1.69 (-0.66%)
AAPL  352.30
-0.48 (-0.14%)
AMD  496.23
-8.05 (-1.60%)
BAC  49.52
-0.55 (-1.11%)
GOOG  278.50
-2.76 (-0.98%)
META  619.73
-6.68 (-1.07%)
MSFT  500.46
-17.53 (-3.38%)
NVDA  155.40
-0.74 (-0.47%)
ORCL  114.94
-4.15 (-3.48%)
TSLA  380.88
+1.14 (0.30%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.